- Report
- December 2021
- 296 Pages
Global
From €2386EUR$2,625USD£2,026GBP
€4772EUR$5,250USD£4,052GBP
- Report
- January 2023
- 131 Pages
Global
From €2272EUR$2,500USD£1,930GBP
- Report
- November 2023
- 157 Pages
Global
From €2136EUR$2,350USD£1,814GBP
- Report
- March 2024
- 90 Pages
United States
From €5408EUR$5,950USD£4,592GBP
- Report
- January 2024
- 110 Pages
Global
From €5408EUR$5,950USD£4,592GBP
- Report
- December 2021
- 100 Pages
Global
From €5408EUR$5,950USD£4,592GBP
- Report
- September 2022
- 94 Pages
Global
From €4499EUR$4,950USD£3,821GBP
- Report
- September 2022
- 62 Pages
Global
From €4499EUR$4,950USD£3,821GBP
- Report
- June 2021
- 77 Pages
Global
From €4499EUR$4,950USD£3,821GBP
From €2272EUR$2,500USD£1,930GBP
- Report
- April 2022
- 120 Pages
Global
From €2272EUR$2,500USD£1,930GBP
- Report
- February 2025
- 85 Pages
India
From €3181EUR$3,500USD£2,701GBP
- Report
- February 2025
- 85 Pages
India
From €3181EUR$3,500USD£2,701GBP
From €3181EUR$3,500USD£2,701GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3181EUR$3,500USD£2,701GBP
From €3181EUR$3,500USD£2,701GBP
- Report
- September 2024
- 82 Pages
Japan
From €3181EUR$3,500USD£2,701GBP
- Report
- April 2024
- 180 Pages
Global
From €4090EUR$4,500USD£3,473GBP
- Report
- April 2024
- 183 Pages
Global
From €4090EUR$4,500USD£3,473GBP
- Report
- April 2024
- 180 Pages
Global
From €4090EUR$4,500USD£3,473GBP

The CAS9 market is a subset of the genomics industry that focuses on the development and use of the CRISPR-Cas9 gene-editing technology. This technology is used to modify the genetic code of living organisms, allowing for the manipulation of genes and the potential to create new treatments for diseases. CAS9 is a powerful tool for researchers, allowing them to make precise changes to the genetic code of organisms.
The CAS9 market is growing rapidly, with many companies investing in the technology and its applications. Companies such as Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences are leading the way in developing and commercializing the technology. Other companies such as Horizon Discovery, Synthego, and Twist Bioscience are also investing in the CAS9 market, providing tools and services to researchers. Show Less Read more